Results 231 to 240 of about 2,052,688 (283)

Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy. [PDF]

Science
Chen Y, Liu Y, Nguyen K, Wu J, Song S, Lin K, Rodrigues PF, Du S, Zhou C, Xiong K, Bosch M, Lin PB, Khantakova D, Wu S, Wu M, Yuede C, Holtzman DM, Colonna M.   +17 more
europepmc   +1 more source

Chimeric antigen receptor T-cell therapy for rheumatic diseases: from B-cell depletion to immune reset and beyond. [PDF]

Front Immunol
Zhan Y, Hu C, Xiao K.
europepmc   +1 more source

Independent validation of the International Metabolic Prognostic Index (CAR‐IMPI) in patients with aggressive diffuse large B‐cell lymphoma treated with CAR‐T

British Journal of Haematology, EarlyView.
Eugenio Galli, Andrea Guarneri, Alessandro Corrente, Francesca Maria Portonera, Elena Romano Gargarella, Ilaria Pansini, Patrizia Chiusolo, Federica Sorà, Maria Lucia Calcagni, Simona Sica, Stefan Hohaus, Lucia Leccisotti   +11 more
wiley   +1 more source

Outcomes for post‐transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study

British Journal of Haematology, EarlyView.
Alexandros Rampotas, Amy A. Kirkwood, Maximillian Brodermann, Nicola Maciocia, Fotios Panitsas, Sridhar Chaganti, Styliani Bouziana, Emma Nicholson, Samantha Drummond, Michelle Lannon, Amy Publicover, Sharon Allen, Isaac Gannon, Andrew J. King, Anne‐Louise Latif, Henry Crosland, Claire Roddie   +16 more
wiley   +1 more source

Reduced‐dose pegylated asparaginase reliably achieves therapeutic levels in adult patients with acute lymphoblastic leukaemia and lymphoblastic lymphoma

British Journal of Haematology, EarlyView.
Leah A. Goldberg, Anjani D. Kapadia, Andrew S. Palmer, Lydia Benitez Colon, Bernard L. Marini, Anthony J. Perissinotti, Dale L. Bixby, Patrick W. Burke, Syed Abdul Mannan Shah, Hamed Rahmani Youshanlouei, Adam S. DuVall, John F. Cursio, Wendy Stock, Emily Dworkin, Anand A. Patel   +14 more
wiley   +1 more source

CHIMERIC ANTIGEN RECEPTOR

, 2017
The present invention is directed to a nucleic acid molecule comprising a polynucleotide sequence encoding a chimeric antigen receptor comprising (a) an anti-CLEC14A binding domain, (b) a transmembrane domain and (c) an intracellular signalling domain ...
ONUOHA SHIMOBI, PULÉ MARTIN, THOMAS SIMON, CORDOBA SHAUN, KOKALAKI EVANGELIA   +4 more
core   +9 more sources

Some of the next articles are maybe not open access.

Related searches:

Chimeric antigen receptors

Nature Biotechnology, 2022
openaire   +2 more sources